| Autor: |
Navid Faraji, Rasoul Goli, Pariya Mohsennezhad, Yousef Mohammadpour, Naser Parizad, Elaheh Salamat, Raheleh Pourbahram, Samaneh Bazbandi |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Toxicology Reports, Vol 12, Iss , Pp 289-291 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2214-7500 |
| DOI: |
10.1016/j.toxrep.2024.02.006 |
| Popis: |
Stevens-Johnson Syndrome (SJS) is a severe and rare adverse drug reaction associated with significant morbidity and mortality. Although SJS is commonly triggered by multiple drugs, non-steroidal anti-inflammatory drugs (NSAIDs), including diclofenac, have been frequently implicated. A middle-aged woman, who is 50 years old, has a prior medical record of high blood pressure, type 2 diabetes, and has recently suffered from a pulmonary embolism. She was later admitted to the intensive care unit (ICU), where she was ultimately diagnosed with Steven Johnson syndrome. Careful drug selection, close monitoring of patients with predisposing factors, and prompt identification of adverse events are crucial to prevent severe drug reactions. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
